News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,081 Results
Type
Article (86506)
Company Profile (702)
Press Release (759873)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232690)
Career Advice (4127)
Deals (39721)
Drug Delivery (129)
Drug Development (90987)
Employer Resources (198)
FDA (18111)
Job Trends (17337)
News (396475)
Policy (39749)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (95)
Alliances (56840)
ALS (103)
Alzheimer's disease (1504)
Antibody-drug conjugate (ADC) (161)
Approvals (18069)
Artificial intelligence (332)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (313)
Cancer (2485)
Cardiovascular disease (210)
Career advice (3535)
Career pathing (34)
CAR-T (175)
Cell therapy (499)
Cervical cancer (22)
Clinical research (73471)
Collaboration (929)
Company closure (1)
Compensation (576)
Complete response letters (30)
COVID-19 (2869)
CRISPR (50)
C-suite (275)
Cystic fibrosis (109)
Data (2355)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (303)
Diagnostics (6929)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (130)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (96910)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130201)
Executive appointments (787)
FDA (19522)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (832)
Gene editing (125)
Generative AI (35)
Gene therapy (366)
GLP-1 (862)
Government (5169)
Grass and pollen (6)
Guidances (130)
Healthcare (20889)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (150)
Indications (30)
Infectious disease (3033)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (59)
Intellectual property (102)
Interviews (813)
IPO (17828)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (45)
Layoffs (561)
Leadership (24)
Legal (10114)
Liver cancer (82)
Lung cancer (349)
Lymphoma (161)
Machine learning (8)
Management (65)
Manufacturing (370)
MASH (79)
Medical device (14642)
Medtech (14647)
Mergers & acquisitions (22455)
Metabolic disorders (806)
Multiple sclerosis (89)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (34)
Neuroscience (2122)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (41)
Obesity (433)
Opinion (275)
Ovarian cancer (81)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (163)
Partnered (24)
Patents (258)
Patient recruitment (119)
Peanut (51)
People (65338)
Pharmaceutical (143)
Pharmacy benefit managers (22)
Phase I (22670)
Phase II (31905)
Phase III (24032)
Pipeline (1360)
Policy (179)
Postmarket research (3552)
Preclinical (10232)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (436)
Real estate (7392)
Recruiting (75)
Regulatory (26830)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (144)
Series B (94)
Service/supplier (30)
Sickle cell disease (59)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4294)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (53)
The Weekly (83)
Vaccines (822)
Venture capitalists (45)
Weight loss (306)
Women's health (40)
Worklife (20)
Date
Today (198)
Last 7 days (963)
Last 30 days (3236)
Last 365 days (35731)
2025 (12620)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (270)
Arkansas (14)
Asia (50161)
Australia (8835)
California (6631)
Canada (2094)
China (572)
Colorado (289)
Connecticut (306)
Delaware (168)
Europe (115098)
Florida (969)
Georgia (223)
Hawaii (1)
Idaho (64)
Illinois (641)
India (31)
Indiana (343)
Iowa (12)
Japan (175)
Kansas (112)
Kentucky (28)
Louisiana (15)
Maine (70)
Maryland (988)
Massachusetts (5077)
Michigan (252)
Minnesota (428)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (69)
New Hampshire (70)
New Jersey (1861)
New Mexico (31)
New York (1867)
North Carolina (1145)
North Dakota (9)
Northern California (2847)
Ohio (224)
Oklahoma (15)
Oregon (48)
Pennsylvania (1459)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (26)
South Dakota (1)
Southern California (2460)
Tennessee (107)
Texas (998)
United States (25382)
Utah (198)
Virginia (177)
Washington D.C. (72)
Washington State (613)
West Virginia (3)
Wisconsin (72)
There are 847,081 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy
1,000 GMP doses of MDMA now reaching patients with PTSD under Australia’s Authorised Prescriber Scheme; Department of Veterans’ Affairs to fund treatment for veterans
May 8, 2025
·
5 min read
Press Releases
Cybin Announces Additional U.S. Patent Supporting its CYB003 Breakthrough Therapy Program in Phase 3 Development for Major Depressive Disorder
May 8, 2025
·
5 min read
Press Releases
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21
May 8, 2025
·
2 min read
Press Releases
CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
May 8, 2025
·
4 min read
Job Trends
Job Market Woes: More Funding, Stability Needed for Turnaround
The biopharma job market likely won’t turn around until 2026, according to two industry experts. Both cited a need for more investment and noted the impact of uncertainty on the industry.
May 8, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Neurocrine Biosciences Announces New Results from Exploratory Analyses of the Phase 3 CAHtalyst™ Pediatric Study Demonstrating CRENESSITY™ Reduces Glucocorticoid Dosing While Maintaining or Improving Androstenedione Across Patient Subgroups
May 8, 2025
·
12 min read
Press Releases
Moderna to Present at Upcoming Bernstein’s 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
May 8, 2025
·
1 min read
Press Releases
Veru Participates in a Virtual Investor KOL Connect Segment
May 8, 2025
·
6 min read
Press Releases
Peptone Establishes Strategic Partnership with Evotec to Selectively Target Intrinsically Disordered Proteins (IDPs) and Advance Small-Molecule Therapeutics at Scale
May 8, 2025
·
4 min read
Press Releases
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025
May 8, 2025
·
6 min read
1 of 84,709
Next
